Tuesday January 11, 2022
During this COVID-19 pandemic and other future events, the CDM has been and will continue
to be a source of reliable information, education and models for mitigation, preparedness,
response, and recovery. We hope this informational document has helped provide you
filtered and actionable information. As the pace of new information and changes occur, we
will evaluate the current once per week to determine if this information should be provided on
a more frequent basis.

David Markenson, M.D., M.B.A.
Director
Center for Disaster Medicine

COVID-19 Statistics

Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

310,481,818

5,494,848

9,443,172,790

United States

61,558,085

839,500

517,806,854

New Jersey

1,866,735

29,494

15,343,050

New York

4,205,019

60,689

35,214,320

Connecticut

605,116

9,377

6,846,483

Information as of 1/11/22 at 0100 EST. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Center for Disaster Medicine Updates
•
•
•

Coordinating and overseeing COVID-19 screenings at NYMC campus
Continue to partner with local organizations such as Westchester Department of Emergency
Services and Westchester Medical Center to ensure ongoing collaboration with all public
safety agencies.
Coordinating volunteers to support local public health response to COVID-19.

•
•
•
•
•

Conducting research and analysis of current events and COVID-19 response to identify
strengths and areas for improvement in other regions.
Updating and developing new programs to provide enhanced education on public health
emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline
responders in the hospital and in the field.
Serving as a source of information for COVID-19 related concerns or questions regarding
public health, emergency medical service (EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using firstperson experiences to highlight current trends.

The White House
On January 5, 2022, White House COVID-19 Response Team and Public Health Officials
provided a press briefing- Drs. Fauci and Walensky provided an update regarding the COVID-19
response.
https://www.whitehouse.gov/briefing-room/press-briefings/2022/01/05/press-briefing-by-whitehouse-covid-19-response-team-and-public-health-officials-77/
Health and Human Services (HHS)
On January 5, 2022, following actions by the Centers for Disease Control and Prevention and
the Food and Drug Administration to expand Pfizer COVID-19 booster shots to 12 to 15 yearolds, HHS Secretary Xavier Becerra issued this statement regarding the Pfizer COIVD-19
booster shot.
https://www.hhs.gov/about/news/2022/01/05/hhs-secretary-becerra-12-to-15-year-olds-can-nowget-pfizer-booster.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html
National Institutes of Health (NIH)
View the latest COVID-19 information from NIH
https://www.nih.gov/coronavirus

United States Food and Drug Administration (FDA)
As of January 7, 2022, 420 tests and sample collection devices are authorized by the
FDA under emergency use authorizations (EUAs). These include 290 molecular tests and
sample collection devices, 87 antibody and other immune response tests and 43 antigen
tests. There are 69 molecular authorizations and one antibody authorization that can be
used with home-collected samples. There is one EUA for a molecular prescription athome test, three EUAs for antigen prescription at-home tests, 13 EUAs for antigen overthe-counter (OTC) at-home tests and three EUAs for molecular OTC at-home tests. The

FDA has authorized 24 antigen tests and nine molecular tests for serial screening
programs. The FDA has also authorized 751 revisions to EUA authorizations.
https://www.fda.gov/news-events/press-announcements/fda-roundup-january-7-2022
On January 7, 2022, FDA Shortens Interval for Booster Dose of Moderna COVID-19
Vaccine to Five Months- the U.S. Food and Drug Administration amended the emergency
use authorization (EUA) for the Moderna COVID-19 Vaccine to shorten the time between
the completion of a primary series of the vaccine and a booster dose to at least five
months for individuals 18 years of age and older.
https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fdashortens-interval-booster-dose-moderna-covid-19-vaccine-five-months
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-andemerging-threats/coronavirus-disease-2019-covid-19
Centers for Disease Control and Prevention (CDC)
On January 7, 2022, CDC Recommends Moderna Booster at 5 Months- CDC is adjusting
our recommendation for when people can receive a booster shot, shortening the interval
from 6 months to 5 months. Earlier this week CDC made this recommendation for
recipients of a Pfizer-BioNTech primary series and, after FDA action this morning, we’re
extending this recommendation to recipients of a Moderna primary series. This means
that people who initially received an mRNA vaccine series – two doses of Moderna or
Pfizer-BioNTech – can now receive an mRNA booster shot 5 months after completing
their initial series.
https://www.cdc.gov/media/releases/2022/s0107-moderna-booster.html
On January 5, 2022, CDC Expands Booster Shot Eligibility and Strengthens
Recommendations for 12-17 Year Olds- CDC is endorsing the Advisory Committee on
Immunization Practices’ (ACIP) recommendation to expand eligibility of booster doses to
those 12 to 15 years old. CDC now recommends that adolescents age 12 to 17 years old
should receive a booster shot 5 months after their initial Pfizer-BioNTech vaccination
series.
https://www.cdc.gov/media/releases/2022/s0105-Booster-Shot.html
On January 4, 2022, CDC Recommends Pfizer Booster at 5 Months, Additional Primary
Dose for Certain Immunocompromised Children- CDC is updating our recommendation
for when many people can receive a booster shot, shortening the interval from 6 months
to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine. This
means that people can now receive an mRNA booster shot 5 months after completing
their Pfizer-BioNTech primary series. The booster interval recommendation for people
who received the J&J vaccine (2 months) or the Moderna vaccine (6 months), has not
changed.
https://www.cdc.gov/media/releases/2022/s0104-Pfizer-Booster.html
CDC provides updated information about the variants in the United States- The emerging
variants CDC is closely monitoring have mutations in the virus genome that alter the

characteristics and cause the virus to act differently in ways that are significant to public
health (e.g., causes more severe disease, spreads more easily between humans,
requires different treatments, changes the effectiveness of current vaccines). It’s
important to understand that genetic mutations are expected, and some variants can
spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and
trends of COVID-19 in the United States- updated daily by 8 pm ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html

Center for Medicare and Medicaid Services (CMS) +
Vaccines
In this section, vaccine-related information from various sources will be collected,
reviewed, and tabulated here. As of January 11, 2022, the FDA has granted Emergency
Use Authorization (EUA) to Moderna and Janssen/Johnson & Johnson. On August 23,
2021, the FDA granted full approval to Pfizer. Now with two vaccines with EUA and one
vaccine with full FDA approval, the goal is to vaccinate a larger number of persons in the
coming months throughout the United States. As additional vaccines are granted EUA,
information for those vaccines will also be included.
CDC created this section regarding COVID-19 vaccinations in the United States- CDC
provides overall US COVID-19 Vaccine, deliveries and administration, maps, charts, and
data updated daily by 8 PM. This section represents all vaccine partners including
jurisdictional partner clinics, retail pharmacies, long-term care facilities, Federal
Emergency Management Agency and Health Resources and Services Administration
partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the
distribution of the vaccine including the number of doses received by the state, a
breakdown of first or second doses, and the number of persons vaccinated with the first
and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
On January 10, 2022, Governor Hochul updated New Yorkers on State's Progress
Combating COVID-19- "We have the tools to fight this winter surge, and how quickly we
turn the corner will depend on our actions," Governor Hochul said. "Please get your
second dose if you haven't already, and get the booster if you're eligible. Parents and
guardians, please get your children vaccinated. Wear a mask to help stop the spread, and
stay home if you aren't feeling well. Let's learn from the lessons of the past and finally put
this winter surge behind us."

https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-statesprogress-combating-covid-19-135
On January 10, 2022, Governor Hochul announced 10 additional SUNY campus-based
COVID-19 test sites will open beginning January 11. The Governor announced the
establishment of these sites last week. "We are not defenseless as we fight the winter
surge: vaccines, boosters and testing can help us slow the spread and protect our loved
ones," Governor Hochul said. "These new SUNY sites build on our ongoing efforts to
make testing more available as part of our Winter Surge Plan, and will be part of more
than 2,000 locations statewide where New Yorkers can easily get tested for COVID-19.
We are utilizing every possible State resource to keep New Yorkers safe and protect our
fragile health care system."
https://www.governor.ny.gov/news/governor-hochul-announces-10-additional-sunycampus-testing-sites-open-across-new-york
On January 7, 2022, Governor Hochul announced new guidance recommending booster
doses for all New Yorkers ages 12 and older. The guidance, following action by the CDC,
recommends that people, including the newly authorized 12-15 year-old age group, who
received the Pfizer-BioNTech vaccine should receive a booster dose at least five months
after their second dose; the previous recommended interval was at least six months. In
addition, moderately to severely immunocompromised 5-11-year-olds can receive an
additional primary dose of the Pfizer-BioNTech vaccine 28 days after their second dose.
At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and recommended
for children ages 5-11.
https://www.governor.ny.gov/news/governor-hochul-announces-new-guidance-covid-19booster-doses
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide
updated relevant information including side effects and safety data, clinical trials
demographic statistics, and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics,
and information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic
statistics, and information on how the vaccine works. As of October 16, 2021, the fully
FDA approved Pfizer vaccine will now be known as COMIRNATY for ages 16 and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/PfizerBioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page

The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19
vaccination location. The Vaccine Finder can also provide New Yorkers with information
to schedule vaccination appointments.
https://vaccinefinder.nyc.gov/

Educational Institution Information
• Higher Education
• Colleges that temporarily shifted instruction online due to the surging
Omicron variant of the coronavirus now face the question of when to
resume in-person learning. For a growing number of institutions, the
answer is not yet. Eight institutions in the University of California
system—Berkeley, Davis, Irvine, Los Angeles, Merced, Riverside, San
Diego and Santa Cruz—all operating remotely, extended those plans to
late January, delaying a return to physical classrooms. Duke University
and Seattle University, both of which began the semester with online
classes, have also announced plans to extend the remote instruction
period. Likewise, multiple schools in the California State University
system also announced a late return to in-person classes.
https://www.insidehighered.com/news/2022/01/10/colleges-extendremote-instruction-period-due-omicron
• K-12
• “The COVID-19 pandemic continued disrupting K-12 in 2021, even as
schools were largely able to return to in-person learning in an attempt to
regain some semblance of normalcy. Just this week, surging cases due
to the omicron variant have sent many students back to virtual
classrooms as school was set to resume following winter break. Returns
to the classroom haven’t come without their own hurdles: The pandemic
and its fallout for schools have taken a toll on the mental health and
social-emotional needs of both students and educators, following a highstress year of virtual learning. Districts face shortages of educators and
other school staff as both burnout and coronavirus anxiety surge. Adding
to the struggles, pandemic safety measures and controversy over
curricular topics led to heated and sometimes-threatening discourse in
some communities, influencing several elections in November and raising
the question of whether schools are communicating what they do well
enough. With these factors stretching into 2022 and likely to impact
school districts for years to come...” Read about the concerning trends to
look out for at https://www.k12dive.com/news/8-k-12-trends-to-watch-in2022/616602/
• While the COVID-19 pandemic did uncover many learning equity
issues, it also brought about some positives in the form of investments in
technology and new digital tools like web conferencing that have helped

students, families and teachers better connect. And though many
educators and students were more than ready to return to in-person
learning as schools began reopening last year, many of the new tools
and models adopted during remote learning are being adapted for inclassroom use now. https://www.k12dive.com/news/3-ways-districtleaders-are-adapting-pandemic-learning-experiences/611771/
Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&cit
y=&dist=
American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid19-patients.html

State Updates

New York
• Governor Kathy Hochul announced new efforts to deliver tax relief for thousands of
small businesses and millions of middle class New Yorkers as part of the 2022 State of
the State. The plan will provide $100 million in tax relief for 195,000 small businesses
through increasing a tax return adjustment to reduce small businesses’ gross
business income. The plan will also accelerate the implementation of $1.2 billion in New
York’s existing Middle Class Tax Cut for 6 million New Yorkers which first began to be
implemented in 2018, and establish a $1 billion property tax rebate program to put
money back into the pockets of more than 2 million New Yorkers who have had to
endure rising costs as the pandemic has
progressed. https://www.governor.ny.gov/news/governor-hochul-announces-new-taxrelief-thousands-small-businesses-and-millions-middle-class
• Governor Kathy Hochul announced new guidance recommending booster doses for all
New Yorkers ages 12 and older. The guidance, following action by the CDC,
recommends that people, including the newly authorized 12-15 year-old age group, who
received the Pfizer-BioNTech vaccine should receive a booster dose at least five months
after their second dose; the previous recommended interval was at least six months. In
addition, moderately to severely immunocompromised 5-11-year-olds can receive an
additional primary dose of the Pfizer-BioNTech vaccine 28 days after their second
dose. At this time, only the Pfizer-BioNTech COVID-19 vaccine is authorized and
recommended for children ages 5-11. https://www.governor.ny.gov/news/governorhochul-announces-new-guidance-covid-19-booster-doses
New York State Department of Health (DOH)
For a list of positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information
regarding testing, cases, percentages, and fatalities across New York State. It also breaks down
cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19TrackerMap?%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home

New Jersey
• Governor Murphy announced that the New Jersey National Guard will be deploying to
long-term care facilities throughout New Jersey to assist with COVID-19 response efforts

and to augment facilities’ staffing. This is an extension of Joint Task Force COVID
Guardian, which has provided coordinated assistance to numerous long-term care
facilities since the first weeks of the COVID-19
pandemic. https://nj.gov/governor/news/news/562022/approved/20220106d.shtml
Connecticut
• Governor Ned Lamont announced that the State of Connecticut distributed an allocation
of 670,000 COVID-19 rapid self-tests to public and private K-12 schools and early
childcare providers statewide. The governor explained that this allocation is the first
phase of his administration’s distribution of self-tests for schools and early childcare
providers, and he anticipates additional allocations to be announced in the coming days
as the state continues securing more tests from vendors. https://portal.ct.gov/Office-ofthe-Governor/News/Press-Releases/2022/01-2022/Governor-Lamont-Announces-StateDistribution-of-670000-Tests-for-Schools
• Governor Ned Lamont announced that his administration is launching CareerConneCT,
a program designed to help workers whose employment was impacted by the COVID-19
pandemic. Individuals will now have access to short-term training programs, where they
can earn an industry-recognized credential and enter employment in high-quality and indemand careers. Administered by the Connecticut Office of Workforce Strategy, the
program is supported through $70 million in funding that Governor Lamont and the state
legislature allocated from the state’s share of the federal American Rescue Plan Act.
Under the program, training providers are eligible to apply for grants over the next four
years to design programs that provide industry-recognized credentials and job
placement services across several sectors, including manufacturing, information
technology, healthcare, infrastructure, clean energy, and other in-demand industries.
The program is anticipated to support training for approximately 8,000 participants.
Grants will be issued twice per year, every February and August.
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2022/012022/Governor-Lamont-Launches-CareerConneCT
• Governor Ned Lamont announced that he has signed two executive orders (Executive
Order No. 14B and Executive Order No. 14C) requiring employees of all long-term care
facilities and state hospitals in Connecticut to receive COVID-19 booster shots by
February 11, 2022. The orders are similar to ones he issued last summer (Executive
Order No. 13F and Executive Order No. 13G) that required these employees to receive
their initial COVID-19 vaccination doses by September 27, 2021. In addition to the
governor’s orders, leadership from the Connecticut Hospital Association (CHA) today
announced that they are implementing a similar mandatory booster shot requirement for
all hospital and health system employees and clinical staff statewide.
https://portal.ct.gov/Office-of-the-Governor/News/Press-Releases/2022/012022/Governor-Lamont-Signs-Orders-Requiring-Long-Term-Care-and-HospitalEmployees-To-Receive-Boosters

Local Updates
New York Blood Center (NYBC)
On January 5, 2022, New York Blood Center discovers highly potent small molecules with the power
to fight COVID-19- NYBC leveraged its expertise in infectious diseases and COVID-19 research and
have discovered a set of novel small-molecule pancoronavirus fusion inhibitors. These fusion
inhibitors are designed to halt the spread of the virus in someone infected with COVID-19, including
people infected with COVID-19 variants. This discovery has great potential to be developed as a
treatment for COVID-19, as well as other existing and future coronavirus diseases.
https://www.nybc.org/news/articles/new-york-blood-center-discovers-highly-potent-small-moleculespower-fight-covid-19/
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/
New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
NYC DOHMH launched a new variants data page. The data on this page show how variants of the
virus that causes COVID-19 are spreading in NYC. Variants are versions of the virus with certain
sets of mutations. Some variants may result in a COVID-19 infection that is easier to spread, more
severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page

For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page
For the latest COVID-19 information from NYC DOHMH
https://www1.nyc.gov/site/doh/covid/covid-19-main.page
Westchester County Department of Health
For the latest breakdown of positive cases in Westchester County as of January 9, 2022.
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including how to avoid the latest vaccine scams
offering earlier access to vaccines.
https://health.westchestergov.com/2019-novel-coronavirus
Putnam County Department of Health
Breakdown of positive cases by towns in Putnam County as of January 6, 2022.
https://www.putnamcountyny.com/covid19/
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/
Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of January 10, 2022.
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of January 5, 2022.
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of
January 10, 2022.
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital
Association that covers hospitals in the tri-state area.

https://www.gnyha.org/

Center for Disaster Medicine Media
New York Medical College Leadership News:
The crazy coronavirus vaccine myths and conspiracies that have been debunked by
experts
Daily Post
1/10/2022
https://www.dailypost.co.uk/news/north-wales-news/crazy-coronavirus-vaccine-mythsconspiracies-22667585
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president of government affairs
Confused By The CDC's New COVID Isolation Rules? Here's A Clear Guide.
The Huff Post
1/2/2022
https://www.huffpost.com/entry/cdc-covid-isolation-rules_l_61d72ec0e4b0c7d8b8ad26c2
Robert W. Amler, M.D., M.B.A., dean of the School of Health Sciences and Practice and vice
president of government affairs
Every effort is made to provide accurate and complete information in this newsletter.
However, New York Medical College cannot guarantee that there will be no errors. NYMC
makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of

the contents of the newsletters or the articles linked herein and further expressly disclaims
liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice.
Always seek the advice of your physician or other qualified health provider with any questions
you may have regarding a medical condition.
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